openPR Logo
Press release

Focal Segmental Glomerulosclerosis Drugs Global Market Report 2024 - By Demand, Size, Share, Industry Analysis, Forecast To 2033

08-09-2024 09:18 AM CET | Health & Medicine

Press release from: The Business research company

Focal Segmental Glomerulosclerosis Drugs Market

Focal Segmental Glomerulosclerosis Drugs Market

"The new report published by The Business Research Company, titled Focal Segmental Glomerulosclerosis Drugs Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the focal segmental glomerulosclerosis drugs market size has grown strongly in recent years. It will grow from $14.43 billion in 2023 to $15.77 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The focal segmental glomerulosclerosis drugs market size is expected to see strong growth in the next few years. It will grow to $22.41 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%.

Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12866&type=smp

Elevated Prevalence Of Kidney Infections Fueling Growth In The Focal Segmental Glomerulosclerosis (FSGS) Drugs Market
The rising prevalence of kidney infections is expected to propel the growth of the focal segmental glomerulosclerosis (FSGS) drugs market going forward. A kidney infection, or pyelonephritis, is a severe type of urinary tract infection (UTI) that affects one or both kidneys. Focal segmental glomerulosclerosis (FSGS) drugs, which are used to treat kidney diseases, offer several benefits in managing the condition and improving kidney function by reducing proteinuria, slowdowns the progression of kidney damage, and helping the patients suffering from kidney diseases with improved quality of life. For instance, in July 2022, according to the Centers for Disease Control and Prevention, a US-based Department of Health and Human Services, around 15%, or 37 million people in the US, were affected by kidney disease. The prevalence among individuals aged 45-64 is 12% and the prevalence among people between 18 and 44 was 6% in 2021. Therefore, the rising prevalence of kidney infections drives the focal segmental glomerulosclerosis (FSGS) market.

Introduction Of Novel Drugs, Gaining FDA Approval, And Orphan Drug Designation
Major companies operating in the focal segmental glomerulosclerosis (FSGS) market are increasingly focusing on product development and innovation to provide reliable products to their customers and strengthen their market position. For instance, in February 2023, Travere Therapeutics, a US-based biopharmaceutical company, launched FILSPARI, for focal segmental glomerulosclerosis (FSGS), which was approved by the Food and Drug Administration (FDA), a US-based federal agency. It is an oral medicine for treating IgA nephropathy (IgAN). It is the first and only non-immunosuppressive treatment for lowering proteinuria in IgAN, a rare kidney disease. Additionally, FILSPARI has been given orphan drug designation in the United States and Europe for treating IgAN and focal segmental glomerulosclerosis (FSGS).

The focal segmental glomerulosclerosis drugs market covered in this report is segmented -
1) By Type: Losmapimod; SHP-627; Sparsentan; TM-5484; Other Types
2) By Treatment: Corticosteroids; Immunosuppressive Drugs; Angiotensin Converting Enzymes (ACE) Inhibitors; A.R. Blockers; Diuretics; Other Treatments
3) By Route of Administration: Oral; Parenteral
4) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12866&type=discount

Major players in the focal segmental glomerulosclerosis drugs market are Pfizer Inc., Johnson and Johnson Ltd., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca PLC, Fresenius Kabi Ltd., GSK PLC, Medtronic Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Astellas Pharma Inc., Otsuka Pharmaceutical Co. Ltd., Mylan N.V., B. Braun Melsungen AG, Hikma Pharmaceuticals PLC, Alexion Pharmaceuticals, Wockhardt, Travere Therapeutics, Aurinia Pharmaceuticals Inc., Omeros Corporation, Dimerix Ltd., Goldfinch Bio.

Contents of the report:
1. Executive Summary
2. Focal Segmental Glomerulosclerosis Drugs Market Report Structure
3. Focal Segmental Glomerulosclerosis Drugs Market Trends And Strategies
4. Focal Segmental Glomerulosclerosis Drugs Market - Macro Economic Scenario
5. Focal Segmental Glomerulosclerosis Drugs Market Size And Growth
…..
27. Focal Segmental Glomerulosclerosis Drugs Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/focal-segmental-glomerulosclerosis-drugs-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Focal Segmental Glomerulosclerosis Drugs Global Market Report 2024 - By Demand, Size, Share, Industry Analysis, Forecast To 2033 here

News-ID: 3616901 • Views:

More Releases from The Business research company

Emerging Trends to Drive Artificial Intelligence Software Platform Market Growth at 31.8% CAGR Through 2029
Emerging Trends to Drive Artificial Intelligence Software Platform Market Growth …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Artificial Intelligence Software Platform Market Through 2025? Over the past years, the market size of the artificial intelligence software platform has experienced an explosive growth. The market, valued at $59.1 billion in 2024, is projected to expand to $79.38 billion in 2025,
Surge Of AI Workloads Drives The Artificial Intelligence Server Market: Strategic Insights Driving Artificial Intelligence Server Market Momentum in 2025
Surge Of AI Workloads Drives The Artificial Intelligence Server Market: Strategi …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Artificial Intelligence Server Market Size Growth Forecast: What to Expect by 2025? In recent times, the artificial intelligence server market has seen significant growth. Expected to expand from $24.53 billion in 2024 to $29.42 billion in 2025, it has a projected compound annual growth rate (CAGR) of 19.9%. Factors
Artificial Intelligence Products Market Soars With Increasing Initiatives: Powering Innovation and Expansion in the Global Artificial Intelligence Products Market by 2025
Artificial Intelligence Products Market Soars With Increasing Initiatives: Power …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Artificial Intelligence Products Industry Market Size Be by 2025? The market size for artificial intelligence products has seen robust growth in the past few years. There will be an increase from $2.53 billion in 2024 to $2.69 billion in 2025, with a compound annual growth rate
Automotive Industry Growth Fuels Expansion Of The Artificial Intelligence Platform Market: The Driving Engine Behind Artificial Intelligence Platforms Market Evolution in 2025
Automotive Industry Growth Fuels Expansion Of The Artificial Intelligence Platfo …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Artificial Intelligence Platforms Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The size of the market for artificial intelligence platforms has seen exponential growth in the past few years. We anticipate it to escalate from $15.2 billion in 2024 to a staggering $19.36 billion in

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase